Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19.
Saved in:
| Title: | Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. |
|---|---|
| Authors: | Apple AC; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA., Oddi A; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA., Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA., Asken BM; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA., Henrich TJ; Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA., Kelly JD; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, USA.; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, USA., Pleasure SJ; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology, University of California, San Francisco, San Francisco, California, USA., Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, California, USA., Allen IE; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, USA., Martin JN; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, California, USA., Ndhlovu LC; Division of Infectious Disease, Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Miller BL; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA., Stephens ML; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA., Hellmuth J; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA.; Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA. |
| Source: | Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 Feb; Vol. 9 (2), pp. 221-226. Date of Electronic Publication: 2022 Jan 19. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
